Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK8 | P45983 | 1/20 | 0.61 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.61 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.61 |
| ▸ | RAMP3 | O60896 | 8/20 | 0.61 |
| ▸ | CALCR | P30988 | 8/20 | 0.61 |
| ▸ | NPY2R | P49146 | 8/20 | 0.60 |
| ▸ | NPY4R | P50391 | 8/20 | 0.60 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.60 |
| ▸ | NPY1R | P25929 | 6/20 | 0.60 |
| ▸ | EP300 | Q09472 | 1/20 | 0.57 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.57 |
| ▸ | NMUR2 | Q9GZQ4 | 1/20 | 0.57 |
| ▸ | NMUR1 | Q9HB89 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29430209 | 0.98 | MAPK8 (0.64) | MAPK8MAPK9MAPK10RAMP3CALCR | |
| SCHEMBL29531542 | 0.95 | NPY2R (0.63) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30495721 | 0.94 | NPY2R (0.65) | RAMP3CALCRNPY2RNPY4RNPY5R | |
| SCHEMBL31222190 | 0.92 | RAMP3 (0.55) | RAMP3CALCRNPY2RNPY4RNPY5R | |
| SCHEMBL31281288 | 0.91 | MAPK8 (0.60) | MAPK8MAPK9MAPK10RAMP3CALCR | |
| SCHEMBL31182879 | 0.91 | RAMP3 (0.61) | MAPK8MAPK9MAPK10RAMP3CALCR | |
| SCHEMBL31000921 | 0.90 | NPY2R (0.63) | MAPK8MAPK9MAPK10RAMP3CALCR | |
| SCHEMBL30495594 | 0.90 | NPY2R (0.68) | RAMP3CALCRNPY2RNPY4RNPY5R | |
| SCHEMBL29562124 | 0.90 | NPY2R (0.67) | MAPK8MAPK9MAPK10RAMP3CALCR | |
| SCHEMBL30423109 | 0.89 | APLNR (0.60) | MAPK8MAPK9MAPK10RAMP3CALCR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220073636-A1 | ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L | DOMANTIS LIMITED (GB) | 2022-03-10 | — | — | US | disclosed |